Biopharma Credit — NEW INVESTMENT OF UP TO US$50M IN CORMEDIX INC.

(LSE:BPCP) BioPharma Credit announced a new investment of up to US$50 million in CorMedix Inc. The investment amount is stated as up to US$50 million. The announcement does not specify the structure, terms, or timing of the investment. No additional financial or operational figures are disclosed in the announcement. The release does not mention any named executives or provide further details about the investment agreement. No information is provided regarding the use of proceeds, closing conditions, or regulatory approvals. The announcement does not include any statements about CorMedix Inc.'s business, products, or financial performance. No counterparties, agencies, or courts are named beyond CorMedix Inc. and BioPharma Credit. No material dates, deadlines, or docket numbers are disclosed. The announcement does not reference any locations. No information is provided about options, shares, or other securities compensation. The notice does not include any forward-looking statements or projections. The announcement is limited to the disclosure of the investment amount and the parties involved.